BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21829026)

  • 1. Management of patients with hepatocellular carcinoma and extrahepatic metastasis.
    Lee HS
    Dig Dis; 2011; 29(3):333-8. PubMed ID: 21829026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases.
    Jung SM; Jang JW; You CR; Yoo SH; Kwon JH; Bae SH; Choi JY; Yoon SK; Chung KW; Kay CS; Jung HS
    J Gastroenterol Hepatol; 2012 Apr; 27(4):684-9. PubMed ID: 21916984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases.
    Yoo JJ; Lee JH; Lee SH; Lee M; Lee DH; Cho Y; Lee YB; Yu SJ; Kim HC; Kim YJ; Yoon JH; Kim CY; Lee HS
    PLoS One; 2014; 9(11):e113926. PubMed ID: 25427152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of hepatocellular carcinoma with extrahepatic metastases.
    Natsuizaka M; Omura T; Akaike T; Kuwata Y; Yamazaki K; Sato T; Karino Y; Toyota J; Suga T; Asaka M
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1781-7. PubMed ID: 16246200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors.
    Uchino K; Tateishi R; Shiina S; Kanda M; Masuzaki R; Kondo Y; Goto T; Omata M; Yoshida H; Koike K
    Cancer; 2011 Oct; 117(19):4475-83. PubMed ID: 21437884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
    Kim J; Sinn DH; Choi MS; Kang W; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW
    PLoS One; 2019; 14(3):e0213547. PubMed ID: 30845192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.
    Lygidakis NJ; Konstantinidou T; Pothoulakis J
    Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma.
    Chua TC; Morris DL
    Surg Oncol; 2012 Jun; 21(2):95-101. PubMed ID: 21397495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M
    Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for extrahepatic metastases by additional staging modalities is required for hepatocellular carcinoma patients beyond modified UICC stage T1.
    Yi J; Gwak GY; Sinn DH; Kim YJ; Kim HN; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2013; 60(122):328-32. PubMed ID: 23241421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hepatocellular carcinoma.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2003; 3(1):8-24. PubMed ID: 12684589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
    Lencioni R; Chen XP; Dagher L; Venook AP
    Oncologist; 2010; 15 Suppl 4():42-52. PubMed ID: 21115580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hepatocellular carcinoma.
    Lau WY
    J R Coll Surg Edinb; 2002 Feb; 47(1):389-99. PubMed ID: 11874260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors.
    Kanda M; Tateishi R; Yoshida H; Sato T; Masuzaki R; Ohki T; Imamura J; Goto T; Yoshida H; Hamamura K; Obi S; Kanai F; Shiina S; Omata M
    Liver Int; 2008 Nov; 28(9):1256-63. PubMed ID: 18710423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?
    Mahady SE; Charlton B; Fitzgerald P; Koorey DJ; Perry JF; Waugh RC; McCaughan GW; Strasser SI
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1299-305. PubMed ID: 20594260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?
    Zhu AX
    Oncologist; 2006; 11(7):790-800. PubMed ID: 16880238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A long-term survival case of hepatocellular carcinoma with bone metastasis and inferior vena cava tumor thrombus successfully treated with multidisciplinary therapy].
    Yamada D; Wada H; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2670-2. PubMed ID: 21224675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection.
    Yang Y; Nagano H; Ota H; Morimoto O; Nakamura M; Wada H; Noda T; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshita K; Nakamori S; Wakasa K; Sakon M; Monden M
    Surgery; 2007 Feb; 141(2):196-202. PubMed ID: 17263976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection.
    Aramaki M; Kawano K; Kai T; Yokoyama H; Morii Y; Sasaki A; Yoshida T; Kitano S
    Hepatogastroenterology; 1999; 46(29):2931-4. PubMed ID: 10576375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hepatocellular carcinoma.
    Forner A; Hessheimer AJ; Isabel Real M; Bruix J
    Crit Rev Oncol Hematol; 2006 Nov; 60(2):89-98. PubMed ID: 16860993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.